University of North Texas System Board of Regents Meeting Agenda February 2026
UNT Health Authorizes ESK Therapeutics Board Appointment
Trusted by teams at
Description
UNT Health received Board approval to have Dr. Kyle Emmitte represent the university on the board of ESK Therapeutics, Inc., a start-up commercializing UNT Health research. This move supports ongoing technology transfer and commercialization strategies.
Contract Details
Vendor
ESK THERAPEUTICS INC
Agency
University Of North Texas System, TX
Contract Type
OTHER
Document Date
February 19, 2026
Contract Term
Ongoing board representation
Renewal Info
Board appointment subject to review as institutional representation changes; ongoing unless replaced by Board
More from ESK THERAPEUTICS INC
Related Contracts
More from University Of North Texas System
University of North Texas System Board of Regents Meeting Agenda Packet May 2026
University of North Texas System Board of Regents Meeting Agenda May 2026
University of North Texas System Board of Regents Meeting Report May 2026
University of North Texas System Board of Regents Meeting Agenda Packet May 2026
University of North Texas System Board of Regents Meeting Agenda February 2026
Want to learn more?
Get alerts on contract renewals, new awards, and vendor activity.
Bring us your territory.
We'll show you what is forming.
See live SLED buying signals, source docs, decision-makers, contract context, and the next step into your CRM or pipeline.